DAILY SABAH
Turkey’s Promising biotech startup raises $12M in Series A Investment Round
About RS Research
This author has not written his bio yet.
But we are proud to say that RS Research contributed 66 entries already.
Entries by RS Research
RS Research’e 12 Milyon Dolar Yatırım
Onkoloji alanında akıllı ilaç adayları geliştiren biyoteknoloji girişimi RS Research, Seri-A turunda GEN İlaç, İstanbul Portföy ve Eczacıbaşı Momentum’dan 12 milyon dolar yatırım aldı. […]
RS Research has raised $12 million
Clinical-stage biotechnology start-up developing smart nanomedicines in oncology raised $12 Million at Series-A Round with investors GEN, OneLife and Eczacıbaşı Momentum. This funding will help the company gain speed in the clinical development of its portfolio as well as become […]
WEBRAZZI
RS Research has raised $12M in Series-A investment round with GEN Ilac as the lead investor
HURRIYET
RS Research’s smart targeted drug candidate started phase-I clinical trial, recruiting patients
DUNYA
Turkey’s first new drug started phase-I clinical study
SABAH
Developing smart chemotherapy drugs against cancer, RS Research kicks-off Series-A funding round
MILLIYET
Named one of the 3 pioneers in science
EKONOMIST
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER
TURKONFED BIZ
Potential power of start-up ecosystem: Women
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
